Nombre de documents

48

CV de Dominique Heymann


Article dans une revue48 documents

  • Marta Tellez-Gabriel, Benjamin Ory, François Lamoureux, Marie-Françoise Heymann, Dominique Heymann. Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis. International Journal of Molecular Sciences , MDPI, 2017, 17, pp.2142 - 2142. <10.3390/ijms17122142>. <inserm-01466086>
  • Zahia Benslimane-Ahmim, Jessica Pereira, Anna Lokajczyk, Blandine Dizier, Isabelle Galy-Fauroux, et al.. Osteoprotegerin regulates cancer cell migration through SDF-1/CXCR4 axis and promotes tumour development by increasing neovascularization. Cancer Letters, Elsevier, 2017, [Epub ahead of print]. <inserm-01480323>
  • Marguerite Chemel, Régis Brion, Aude Segaliny, Audrey Lamora, Céline Charrier, et al.. BMP-2 and TGF-β1 inhibit the expression of the pro-inflammatory cytokine IL-34 in rheumatoid arthritis synovial fibroblasts. American Journal of Pathology, American Society for Investigative Pathology, 2017, 187 (1), pp.156-162. <10.1016/j.ajpath.2016.09.015>. <inserm-01466118>
  • Guillaume Aubin, Marc Baud 'Huin, Jean-Philippe Lavigne, Régis Brion, François Gouin, et al.. Interaction of Cutibacterium (formerly Propionibacterium) acnes with bone cells: a step toward understanding bone and joint infection development. Scientific Reports, Nature Publishing Group, 2017, 7, Epub ahead of print. <10.1155/2015/218918>. <inserm-01490369>
  • Marie-Françoise Heymann, Hannah Brown, Dominique Heymann. Drugs in early clinical development for the treatment of osteosarcoma . Expert Opinion on Investigational Drugs, Taylor & Francis, 2017, 25 (11), pp.1265-1280. <10.1080/13543784.2016.1237503>. <inserm-01466096>
  • Hannah Brown, Kristina Schiavone, Simon Tazzyman, Dominique Heymann, Thimothy Chico. Zebrafish xenograft models of cancer and metastasis for drug discovery. Expert Opinion on Drug Discovery, Informa Healthcare, 2017, Epub ahead of print. <10.1080/17460441.2017.1297416>. <inserm-01490365v2>
  • Mazène Hochane, Valérie Trichet, Claire Pecqueur, Pierre Avril, Lisa Oliver, et al.. Low-Dose Pesticide Mixture Induces Senescence In Normal Mesenchymal Stem Cells (MSC) And Promotes Tumorigenic PhenotypeIn Premalignant MSC. STEM CELLS, AlphaMed Press, 2016. <inserm-01398601>
  • Hannah Brown, Marta Tellez-Gabriel, Dominique Heymann. Cancer stem cells in Osteosarcoma: Stem cells and osteosarcoma. Cancer Letters, Elsevier, 2016, 386, pp.189-195. <10.1016/j.canlet.2016.11.019>. <inserm-01466078>
  • Marta Gabriel, Lidia Calleja, Antoine Chalopin, Benjamin Ory, Dominique Heymann. Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation. Clinical Chemistry, American Association for Clinical Chemistry, 2016, 62 (4), pp.571 - 581. <10.1373/clinchem.2015.249706>. <inserm-01466107>
  • Guillaume Odri, Pui-Pui Kim, François Lamoureux, Céline Charrier, Séverine Battaglia, et al.. Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing's sarcoma via inhibition of cell migration.. BMC Cancer, BioMed Central, 2014, 14 (1), pp.169. <10.1186/1471-2407-14-169>. <inserm-00973202>
  • Guillaume E Beranger, Mansour Djedaini, Séverine Battaglia, Christian H Roux, Marcel Scheideler, et al.. Oxytocin reverses osteoporosis in a sex-dependent manner.. Frontiers in Endocrinology, Frontiers, 2014, 6, pp.81. <hal-01255241>
  • Guillaume E Beranger, Didier F Pisani, Julien Castel, Mansour Djedaini, Séverine Battaglia, et al.. Oxytocin reverses ovariectomy-induced osteopenia and body fat gain.. Endocrinology, Endocrine Society, 2014, 155 (4), pp.1340-52. <10.1210/en.2013-1688>. <hal-00968717>
  • Meadhbh Brennan, Audrey Renaud, Jérôme Amiaud, Markus Rojewski, Hubert Schrezenmeier, et al.. Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate.. Current Stem Cell Research & Therapy, Bentham Science Publishers Ltd, 2013, 5 (5), pp.114. <inserm-01205389>
  • Elisabeth Miot-Noirault, Emmanuelle David, Aurélien Vidal, Caroline Peyrode, Sophie Besse, et al.. 99mTc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model.. EJNMMI Research, BioMed Central, 2013, 3 (1), pp.40. <10.1186/2191-219X-3-40>. <inserm-00827007>
  • Jean-Louis Milan, Sandrine Lavenus, Paul Pilet, Guy Louarn, Sylvie Wendling, et al.. Computational model combined with in vitro experiments to analyse mechanotransduction during mesenchymal STEM cell adhesion. eCells and Materials Journal, AO Research Institute Davos, 2013, 25, pp.97. <hal-00961227>
  • Gaëlle Picarda, Valérie Trichet, Stéphane Téletchéa, Dominique Heymann, Françoise Rédini. TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment.. Am J Cancer Res, 2012, 2 (1), pp.45-64. <inserm-00667881>
  • Gatien Moriceau, Anke Roelofs, Régis Brion, Françoise Redini, Frank Ebetino, et al.. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.. Cancer, Wiley, 2012, 118 (3), pp.750-60. <10.1002/cncr.26336>. <inserm-00667512>
  • Dominique Heymann. Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences. Journal of Bone Oncology, 2012, 1 (1), pp.2-11. <10.1016/j.jbo.2012.03.001>. <inserm-00719461>
  • Marc Baud'Huin, Céline Charrier, Gwenola Bougras, Régis Brion, Frédéric Lezot, et al.. Proteoglycans and osteolysis.. Methods in Molecular Biology -Clifton then Totowa-, Humana Press (Springer Imprint), 2012, 836, pp.323-37. <10.1007/978-1-61779-498-8_21>. <inserm-00667515>
  • Steven Georges, Dominique Heymann, Marc Padrines. Modulatory effects of proteoglycans on proteinase activities.. Methods in Molecular Biology -Clifton then Totowa-, Humana Press (Springer Imprint), 2012, 836, pp.307-22. <10.1007/978-1-61779-498-8_20>. <inserm-00667517>
  • Pierre Guihard, Yannic Danger, Bénédicte Brounais, Emmanuelle David, Régis Brion, et al.. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling.. Stem Cells / Stem Cells (Miamisburg), Alphamed Press, 2012, 30 (4), pp.762-72. <10.1002/stem.1040>. <inserm-00668995>
  • M. Chemel, Benoît Le Goff, Régis Brion, C. Cozic, Martine Berreur, et al.. Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients.. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2012, 71 (1), pp.150-4. <10.1136/annrheumdis-2011-200096>. <inserm-00667486>
  • Marie-Françoise Heymann, Fanny Herisson, Jean-Michel Davaine, Céline Charrier, Séverine Battaglia, et al.. Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: Comparison between carotid and femoral beds.: OPG/RANK/RANKL and atherosclerosis. Cytokine, Elsevier, 2012, 58 (2), pp.300-6. <10.1016/j.cyto.2012.02.004>. <inserm-00692423>
  • Kosei Ando, Kanji Mori, Franck Verrecchia, Baud'Huin Marc, Françoise Rédini, et al.. Molecular alterations associated with osteosarcoma development.. Sarcoma, Hindawi Publishing Corporation, 2012, 2012, pp.523432. <10.1155/2012/523432>. <inserm-00692425>
  • Marc Baud'Huin, Carmen Ruiz-Velasco, Gaëtan Jego, Céline Charrier, Nijole Gasiunas, et al.. Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: role in osteoclastogenesis and bone resorption.: glycosaminoglycans and osteoclastogenesis. Eur J Cell Biol, 2011, 90 (1), pp.49-57. <10.1016/j.ejcb.2010.08.001>. <inserm-00667533>
  • Fanny Herisson, Marie-Françoise Heymann, Maud Chétiveaux, Céline Charrier, Séverine Battaglia, et al.. Carotid and femoral atherosclerotic plaques show different morphology.: Patterns of Peripheral Arterial Disease. Atherosclerosis, Elsevier, 2011, 216 (2), pp.348-54. <10.1016/j.atherosclerosis.2011.02.004>. <inserm-00642808>
  • Kosei Ando, Kanji Mori, Nadège Corradini, Françoise Redini, Dominique Heymann. Mifamurtide for the treatment of nonmetastatic osteosarcoma.. Expert Opinion on Pharmacotherapy, Taylor & Francis, 2011, 12 (2), pp.285-92. <10.1517/14656566.2011.543129>. <inserm-00667530>
  • Carmen Ruiz-Velasco, Marc Baud'Huin, Corinne Sinquin, Mike Maillasson, Dominique Heymann, et al.. Effects of a sulfated exopolysaccharide produced by Altermonas infernus on bone biology.. Glycobiology, Oxford University Press (OUP), 2011, 21 (6), pp.781-95. <10.1093/glycob/cwr002>. <inserm-00667495>
  • Emmanuelle David, Frédéric Blanchard, Marie-Françoise Heymann, Gonzague De Pinieux, François Gouin, et al.. The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets.. Sarcoma, Hindawi Publishing Corporation, 2011, 2011, pp.932451. <10.1155/2011/932451>. <inserm-00667904>
  • Gatien Moriceau, Benjamin Ory, Laura Mitrofan, Chiara Riganti, Frédéric Blanchard, et al.. Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process.: Additive effect of ZOL and mTOR on osteosarcoma development. Cancer Research, American Association for Cancer Research, 2010, 70 (24), pp.10329-39. <10.1158/0008-5472.CAN-10-0578>. <inserm-00667504>
  • Gatien Moriceau, Benjamin Ory, Bérengère Gobin, Franck Verrecchia, François Gouin, et al.. Therapeutic approach of primary bone tumours by bisphosphonates.. Current Pharmaceutical Design, Bentham Science Publishers, 2010, 16 (27), pp.2981-7. <inserm-00511241>
  • Dominique Heymann. Bisphosphonates and bone diseases: past, present and future.. Current Pharmaceutical Design, Bentham Science Publishers, 2010, 16 (27), pp.2948-9. <inserm-00667497>
  • Pierre Perrot, Julie Rousseau, Anne-Laure Bouffaut, Françoise Rédini, Elisabeth Cassagnau, et al.. Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence.. PLoS ONE, Public Library of Science, 2010, 5 (6), pp.e10999. <10.1371/journal.pone.0010999>. <inserm-00667931>
  • Benoit Le Goff, Elise Soltner, Céline Charrier, Yves Maugars, Françoise Rédini, et al.. A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis. Arthritis Research & Therapy, BioMed Central, 2009, 11 (6), pp.R185. <10.1186/ar2877>. <inserm-00663553>
  • Kanji Mori, K. Ando, Dominique Heymann, Françoise Rédini. Receptor activator of nuclear factor-kappa B ligand (RANKL) stimulates bone-associated tumors through functional RANK expressed on bone-associated cancer cells?. Histology and Histopathology, Universidad de Murcia, 2009, 24 (2), pp.235-42. <inserm-00667499>
  • Marc Baud'Huin, Laurence Duplomb, Stéphane Téletchéa, Céline Charrier, Mike Maillasson, et al.. Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2009, 284 (46), pp.31704-13. <10.1074/jbc.M109.030312>. <inserm-00667507>
  • Kanji Mori, Frédéric Blanchard, Céline Charrier, Séverine Battaglia, Kosei Ando, et al.. Conditioned media from mouse osteosarcoma cells promote MC3T3-E1 cell proliferation using JAKs and PI3-K/Akt signal crosstalk.. Cancer Science, Wiley Open Access, 2008, 99 (11), pp.2170-6. <10.1111/j.1349-7006.2008.00919.x>. <inserm-00667527>
  • François Lamoureux, Gaelle Picarda, Julie Rousseau, Clothilde Gourden, Séverine Battaglia, et al.. Therapeutic efficacy of soluble receptor activator of nuclear factor-{kappa}B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma.. Molecular Cancer Therapeutics, American Association for Cancer Research, 2008, 7 (10), pp.3389-3398. <10.1158/1535-7163.MCT-08-0497>. <inserm-00332021>
  • Kosei Ando, Kanji Mori, Francoise Rédini, Dominique Heymann. RANKL/RANK/OPG: Key Therapeutic Target in Bone Oncology.. Current Drug Discovery Technologies, Bentham Science Publishers, 2008, 5 (3), pp.263-8. <inserm-00312770>
  • Laurence Duplomb, Marc Baud'Huin, Céline Charrier, Martine Berreur, Valérie Trichet, et al.. Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3.. Endocrinology, Endocrine Society, 2008, 149 (7), pp.3688-97. <10.1210/en.2007-1719>. <inserm-00667501>
  • Benjamin Ory, Gatien Moriceau, Valérie Trichet, Frédéric Blanchard, Martine Berreur, et al.. Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells.: resistance of osteosarcoma to nitrogen bisphosphonates. Journal of Cellular and Molecular Medicine, Wiley Open Access, 2008, 12 (3), pp.928-41. <10.1111/j.1582-4934.2008.00141.x>. <inserm-00667523>
  • Kanji Mori, Martine Berreur, Fréderic Blanchard, Catherine Chevalier, Isabelle Guisle-Marsollier, et al.. Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells.. Oncology Reports, Spandidos Publications, 2007, 18 (6), pp.1365-71. <inserm-00667508>
  • Kanji Mori, Benoît Le Goff, Céline Charrier, Séverine Battaglia, Dominique Heymann, et al.. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.. BONE, Elsevier, 2007, 40 (4), pp.981-90. <10.1016/j.bone.2006.11.006>. <inserm-00667539>
  • Kanji Mori, Françoise Rédini, François Gouin, Bertrand Cherrier, Dominique Heymann. Osteosarcoma: current status of immunotherapy and future trends (Review).. Oncology Reports, Spandidos Publications, 2006, 15 (3), pp.693-700. <inserm-00667509>
  • Dominique Heymann. Autophagy: A protective mechanism in response to stress and inflammation.. Current Opinion in Investigational Drugs, Thomson Reuters (Professional), 2006, 7 (5), pp.443-50. <inserm-00669003>
  • Yohann Wittrant, François Lamoureux, Kanji Mori, Anne Riet, Akira Kamijo, et al.. RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.. International Journal of Oncology, Spandidos Publications, 2006, 28 (1), pp.261-9. <inserm-00667510>
  • Sandrine Théoleyre, Kanji Mori, Bertrand Cherrier, Norbert Passuti, François Gouin, et al.. Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma.. BMC Cancer, BioMed Central, 2005, 5, pp.123. <10.1186/1471-2407-5-123>. <inserm-00089924>
  • Yohann Wittrant, Sandrine Théoleyre, Céline Chipoy, Marc Padrines, Frédéric Blanchard, et al.. RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis.. BBA - Biochimica et Biophysica Acta, Elsevier, 2004, 1704 (2), pp.49-57. <10.1016/j.bbcan.2004.05.002>. <inserm-00669006>